Concepedia

The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis

Tara M. Mackay, F. Jasmijn Smits, Daphne Roos, Bert A. Bonsing, Koop Bosscha, Olivier R. Busch, Geert‐Jan Creemers, Ronald M. van Dam, Casper H.J. van Eijck, Michael F. Gerhards,

HPB · 2019 · 115 citations · 30 references

DOIFull text

Open access

Concepts

References

30

The Clavien-Dindo Classification of Surgical Complications

Pierre A. Clavien, Jeffrey Barkun, Michelle Oliveira et al. · Annals of Surgery · 2009 · 11.3K citations

, , +13

Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)

Moritz N. Wente, Claudio Bassi, Christos Dervenis et al. · Surgery · 2007 · 3K citations

, , +14

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Pascal Hammel, Mohamed Hebbar et al. · New England Journal of Medicine · 2018 · 2.8K citations · Full text

, , +14

Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery

Moritz Koch, O. James Garden, Robert Padbury et al. · Surgery · 2011 · 1.9K citations

, , +17

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

John P. Neoptolemos, Daniel H. Palmer, Paula Ghaneh et al. · The Lancet · 2017 · 1.9K citations · Full text

, , +17